We are live on ! Find out more
BLACU

Bellevue Life Sciences Acquisition Corp. Unit
BLACU

Delisted

BLACU was delisted on the 14th of February, 2025.

Back to rankings

3 hedge funds and large institutions have $61.3K invested in Bellevue Life Sciences Acquisition Corp. Unit in 2024 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

21% more capital invested

Capital invested by funds: $50.8K → $61.3K (+$10.6K)

0% more funds holding

Funds holding: 3 → 3 (0)

Holders
3
Holders Change
–
Holders Change %
0%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CS
Clear Street
New York
+$5.67K

Top Sellers

No sellers this quarter

BLACU Hedge Fund Activity: Q4 2024 in Review

3 of the 7,608 institutional investors tracked by Wall St. Rank reported a position in Bellevue Life Sciences Acquisition Corp. Unit (BLACU) for Q4 2024, worth a combined $61.3K — up 21% from $50.8K a quarter earlier.

Fund positioning in BLACU was balanced in Q4 2024: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.

The largest buyer was Clear Street, adding an estimated $5.67K.

  • 3 institutional investors held Bellevue Life Sciences Acquisition Corp. Unit (BLACU) as of Q4 2024, unchanged from Q3 2024.
  • Funds reported $61.3K of Bellevue Life Sciences Acquisition Corp. Unit stock for Q4 2024, up 21% quarter-over-quarter.
  • 0 funds opened new Bellevue Life Sciences Acquisition Corp. Unit positions in Q4 2024 and 0 closed out.
  • The largest Bellevue Life Sciences Acquisition Corp. Unit buyer in Q4 2024 was Clear Street, an estimated $5.67K added.

Based on aggregated 13F filings for Q4 2024.